Mohammad-Reza Rezvany

Author

Karolinska University Hospital

Also Known As

M R Rezvany, Mohammad-Reza Rezvany, MohammadReza Rezvany

Publications

439

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Sophiahemmet Hospital Karolinska Institutet

About

Mohammad-Reza Rezvany is an author at Karolinska University Hospital specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	210
2	Immunology	3	3	210
3	Health Sciences	1	1	118
4	Cell Biology	1	1	82
5	Pathology	1	1	10

Mohammad-Reza Rezvany

Publications

434

Citations

H-Index

Page 1

	Year	Citations
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia Jeanette Lundin, Anna Porwit‐MacDonald, Eva Rossmann, Leukemia Hematological MalignancyLymphoid NeoplasiaSubcutaneous AlemtuzumabAutoimmune DiseaseCellular Immune Reconstitution	2004	118
Oligoclonal TCRBV Gene Usage in B-Cell Chronic Lymphocytic Leukemia: Major Perturbations Are Preferentially Seen Within the CD4 T-Cell Subset Mohammad-Reza Rezvany, Mahmood Jeddi‐Tehrani, Anders Österborg, Blood	1999	87
Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell–tumour hybrids in B-CLL Parviz Kokhaei, Mohammad-Reza Rezvany, Lena Virving, Leukemia Cancer ImmunosurveillanceDendritic Cell–tumour HybridsImmunologyTumor ImmunityT Cell Immunity	2003	82
Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia Mohammad-Reza Rezvany, Mahmood Jeddi‐Tehrani, Hans Wigzell, Blood	2003	73
Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma Eva Mikaelsson, Amir Hossein Daneshmanesh, Alfred Lüppert, Blood	2005	64
T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody Szilvia Mosolits, Katja Markovic, Jan Fagerberg, Cancer Immunology Immunotherapy Anti-idiotypic AntibodyImmunologyPathologyImmunodominanceColorectal Cancer	2004	10

Page 1